Peptides for IgA Nephropathy: Modulating Immune Responses

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Peptide therapies are emerging as a targeted approach for IgA nephropathy, aiming to modulate immune responses and reduce inflammation in the kidneys. These interventions offer potential to slow disease progression and preserve renal function by addressing the underlying autoimmune pathology.

{" ".join(current_paragraph)}